Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department.

Medicine (Baltimore) · 2016 · PMC4985335 · PMID 27512880

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

at the limit of significanceP < 0.05actually significant

There was only a weak respiratory rate decrease, minus 2/min for each additional 10 mg terbutaline dose, with P value at the limit of significance ( P < 0.05).

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.